Clinical trials in developing countries: scientific and ethical issues

@article{Studdert1998ClinicalTI,
  title={Clinical trials in developing countries: scientific and ethical issues},
  author={D. Studdert and T. Brennan},
  journal={Medical Journal of Australia},
  year={1998},
  volume={169}
}
Since the 1994 finding that intensive zidovudine treatment of mothers and infants can dramatically reduce perinatal transmission of human immunodeficiency virus, this treatment has been widely adopted in developed countries. In developing countries, trials of less‐intensive (and cheaper) regimens have gone ahead, many funded by foreign governments and the United Nations. Controversy has erupted over these trials, particularly over their use of placebo controls. Do differences in healthcare… Expand
Ethics of clinical trials in Nigeria
  • P. Okonta
  • Medicine
  • Nigerian medical journal : journal of the Nigeria Medical Association
  • 2014
TLDR
Current international and national regulatory and ethical guidelines are reviewed to illustrate the requirements for ethical conduct of clinical trials in Nigeria and ways in which these can be avoided. Expand
Ethical Issues with Clinical Trials in Developing Countries
In recent years, the increasingly global nature of health research and the conduct of clinical trials involving human participants have highlighted a number of new ethical issues. This often happensExpand
Conduct of clinical trials in developing countries: a perspective
TLDR
With careful planning in advance and shared partnership among sponsors, host-country research practitioners, government agencies and the community, many of the challenges facing clinical trial research can be overcome over the medium to long term. Expand
Biomedical Research in Developing Countries and International Human Rights Law
At present, considerable numbers of research projects are conducted on a multinational basis. Teams of researchers based in different States may participate in a single project. Furthermore,Expand
Participating in HIV Clinical Trials: Reasons and Experiences Among Women Living With HIV in Thailand
TLDR
The authors discuss the experiences of participating in HIV trials and their ethical concerns among Thai women living with HIV/AIDS and the findings can be valuable for the design and conduct of future HIV clinical trials and the provision of sensitive HIV care for women who are the vulnerable members of society. Expand
Module four: standards of care and clinical trials.
TLDR
This module examines ethical debates about the level of care that should be provided to human research participants and what relevant international and domestic regulatory documents say about standards of care. Expand
Should research ethics change at the border?
  • P. McNeill
  • Medicine
  • The Medical journal of Australia
  • 1998
TLDR
There needs to be recognition, as Deeble indicates, of the higher levels of spending needed for delivering services to Aboriginal communities, and of the need to make the services culturally appropriate. Expand
The Ethical Use of Placebo Controls in Clinical Research: The Declaration of Helsinki
TLDR
An examination of the problem with regard to research involving EEG biofeedback therapy for Attention-Deficit/Hyperactivity Disorder, Traumatic Brain Injury, and depression serves to highlight the issues and concludes that the active treatment control (treatment equivalence) design is most appropriate for those clinical studies examining disorders for which there is a known, effective treatment. Expand
The Importance of Clinical Research for Plant-Derived Medicines
A large number of the most commonly-used medications in developed nations, and the overwhelming majority of those used in developing nations, are plant-derived. However, there is an ambiguity in thisExpand
Development of Plant-Based Medicines: Conservation, Efficacy and Safety
TLDR
This chapter discusses the development of new technologies for Medicinal Plant Species - Panax ginseng and Huperzia serrata: Cryopreservation and Analysis of Secondary Metabolites and the importance of clinical research for Plant-Derived Medicines. Expand
...
1
2
...

References

SHOWING 1-10 OF 13 REFERENCES
Ethical issues in studies in Thailand of the vertical transmission of HIV.
TLDR
It is argued that placebo-controlled trials of treatments to prevent maternal-fetal transmission of HIV infection are sometimes justified in settings where treatment is otherwise totally unavailable because at least half of those involved would likely benefit. Expand
Ethical complexities of conducting research in developing countries.
TLDR
The current debate hinges on the morality of using a placebo control when the AIDS Clinical Trials Group protocol 076 is being effectively used in other parts of the world and the most compelling response to criticisms of the placebo-control test designs is that it provides definitive answers to safety and effectiveness questions in the study setting. Expand
Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries.
TLDR
The authors oppose the use of placebo-controlled trials as unethical in the search for alternative antiretroviral drug regimens to prevent the perinatal transmission of HIV. Expand
The ethics of clinical research in the Third World.
  • M. Angell
  • Medicine
  • The New England journal of medicine
  • 1997
An essential ethical condition for a randomized clinical trial comparing two treatments for a disease is that there be no good reason for thinking one is better than the other.1,2 Usually,Expand
Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.
TLDR
It is suggested that antenatal Oral zidovudine may be as effective as antenatal oral plus intravenous zidvudine during labor and the three-component ACTG 076 regimen in decreasing mother-to-infant HIV-1 transmission. Expand
Reduction of maternal‐infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
  • 1995
cancer, 0.92 [0.771. IO] stromal cancer, 0.92 [0.65-l .32] germcell cancer, 0.93 [O.SO-I.091 borderline tumors). Because our findings cannot be readily explained by theories invoking incessantExpand
AZT price cut for Third World mothers-to-be.
  • M. Waldholz
  • Computer Science, Medicine
  • Wall Street journal
  • 1998
An apology is not enough
  • BostonSundayGlobe
  • 1997
Job itself in doubt as new feud looms on surgeon general
  • TheEconomist
  • 1997
U.S. AIDS research abroad sets off outcry over ethics
  • New York Times
  • 1997
...
1
2
...